Magna International Inc. (MGA) Analysts See $1.58 EPS; PROVECTUS BIOPHARMACEUTICALS INCORPORATE (PVCT) Shorts Increased By 33.22%

January 19, 2018 - By Richard Conner

Analysts expect Magna International Inc. (NYSE:MGA) to report $1.58 EPS on February, 23.They anticipate $0.34 EPS change or 27.42% from last quarter’s $1.24 EPS. MGA’s profit would be $555.79 million giving it 9.24 P/E if the $1.58 EPS is correct. After having $1.36 EPS previously, Magna International Inc.’s analysts see 16.18% EPS growth. The stock decreased 1.80% or $1.07 during the last trading session, reaching $58.4. About 634,174 shares traded. Magna International Inc. (NYSE:MGA) has risen 15.97% since January 19, 2017 and is uptrending. It has underperformed by 0.73% the S&P500.

PROVECTUS BIOPHARMACEUTICALS INCORPORATE (OTCMKTS:PVCT) had an increase of 33.22% in short interest. PVCT’s SI was 115,100 shares in January as released by FINRA. Its up 33.22% from 86,400 shares previously. With 981,600 avg volume, 0 days are for PROVECTUS BIOPHARMACEUTICALS INCORPORATE (OTCMKTS:PVCT)’s short sellers to cover PVCT’s short positions. The stock decreased 1.25% or $0.001 during the last trading session, reaching $0.079. About 270,116 shares traded. Provectus Biopharmaceuticals, Inc. (OTCMKTS:PVCT) has 0.00% since January 19, 2017 and is . It has underperformed by 16.70% the S&P500.

Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. The company has market cap of $29.29 million. The Company’s prescription drug candidates includes PV-10, which is in Phase III study for cutaneous melanoma; completed Phase II study for metastatic melanoma; completed Phase I study for liver and breast cancers; and phase 1b/2 study for pembrolizumab. It currently has negative earnings. The firm is also developing PH-10 that has completed Phase II randomized study for the treatment of psoriasis and atopic dermatitis.

Magna International Inc. designs, develops, and makes automotive systems, assemblies, modules, and components in North America, Europe, Asia, and South America. The company has market cap of $20.54 billion. The firm offers engineering and contract manufacturing services, and fuel systems; electric/electronic components and systems; roof systems comprising softtops, retractable hardtops, modular tops, and hardtops; and closures, including latching systems, hinges and wire forming, power closures, electronics, door modules, window systems engineered glass, sealing, trim and roof racks, roof systems, testing centers, and running boards. It has a 10.42 P/E ratio. It also provides interior and exterior mirrors, actuators, electronic vision systems, door handle and overhead console technologies, and front and signal lightings; complete seating systems, mechanism solutions, seat structure solutions, foam and trim products, and design and development solutions; and fascia and exterior trims, liftgate and exterior modules, front end modules, ACTERO active aerodynamics, and lightweight composites.

Among 14 analysts covering Magna International (NYSE:MGA), 10 have Buy rating, 1 Sell and 3 Hold. Therefore 71% are positive. Magna International had 47 analyst reports since August 6, 2015 according to SRatingsIntel. As per Friday, January 6, the company rating was maintained by RBC Capital Markets. The firm has “Market Perform” rating given on Tuesday, June 28 by BMO Capital Markets. The stock of Magna International Inc. (NYSE:MGA) earned “Outperform” rating by RBC Capital Markets on Thursday, January 14. On Friday, August 14 the stock rating was maintained by Deutsche Bank with “Buy”. BMO Capital Markets maintained the stock with “Hold” rating in Monday, November 6 report. The stock of Magna International Inc. (NYSE:MGA) has “Buy” rating given on Wednesday, January 17 by RBC Capital Markets. The stock has “Sell” rating by Goldman Sachs on Monday, October 16. Citigroup upgraded the shares of MGA in report on Monday, January 25 to “Buy” rating. The rating was maintained by Morgan Stanley on Thursday, March 17 with “Overweight”. Macquarie Research upgraded Magna International Inc. (NYSE:MGA) on Monday, February 27 to “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com